You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for New Zealand Patent: 591443


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for New Zealand Patent: 591443

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Sep 22, 2026 Legacy Pharma ESBRIET pirfenidone
⤷  Start Trial Sep 22, 2026 Legacy Pharma ESBRIET pirfenidone
⤷  Start Trial May 10, 2028 Legacy Pharma ESBRIET pirfenidone
⤷  Start Trial Sep 22, 2026 Legacy Pharma ESBRIET pirfenidone
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape of New Zealand Patent NZ591443

Last updated: July 29, 2025

Introduction

New Zealand patent NZ591443 pertains to a pharmaceutical invention with potential implications for medical treatment, drug manufacturing, or formulation. Analyzing its scope and claims provides essential insights into its strength, breadth, and positioning within the global patent landscape. This report aims to offer a detailed, concise evaluation suitable for professionals involved in pharmaceutical patent strategy, licensing, or market research.

Patent Overview and Basic Details

  • Patent Number: NZ591443
  • Filing/Publication Date: The specific filing and publication dates are not provided here; however, typical patent term considerations apply.
  • Applicant/Inventor: Details indicate a focus on a pharmaceutical compound or formulation, although specifics require access to full patent documents.
  • Jurisdiction: New Zealand, with possible relevance to regional markets and patent extension strategies.

Scope of NZ591443

Legal Scope and Patent Claims

A patent’s scope is primarily defined by its claims, which set out the boundaries of the patent’s exclusive rights. The scope determines which products or processes infringe the patent and influences competitive positioning.

  • Independent Claims: Focused on the core inventive concept, likely covering a novel chemical compound, a method of manufacture, or a specific therapeutic use.
  • Dependent Claims: Specify particular embodiments, formulations, dosages, or manufacturing parameters, thereby narrowing or clarifying the independent claims.

In NZ591443, the scope may encompass:

  • Chemical Composition Claims: Covering a novel active pharmaceutical ingredient (API) or a specific polymorph/formulation.
  • Method Claims: Covering manufacturing processes or therapeutic methods involving the compound.
  • Use Claims: Covering specific medical indications or treatment protocols.

Strength and Breadth

  • Narrow Claims: If the claims focus on specific chemical structures or formulations, the scope remains limited, reducing infringement risk but also limiting market scope.
  • Broad Claims: Claims encompassing a class of compounds or broad therapeutic applications provide higher infringement risk but are more vulnerable to validity challenges if prior art exists.

Claim Construction and Interpretation

Legal interpretation depends on the language used, including terminology like "comprising," "consisting of," etc., which influence the scope. Precise claim drafting aims to balance scope with validity and enforceability.

Patent Landscape for NZ591443

Global Patent Portfolio

Understanding the patent landscape involves identifying:

  • Priority and Family Members: Whether NZ591443 is part of a broader patent family filed in other jurisdictions (e.g., US, EP, PCT). Cross-national filings can provide broader territorial coverage.
  • Related Patent Applications: Investigate if similar patents or applications exist, indicating the applicant’s strategic patenting to carve out market space.
  • Patent Expiry and Maintenance: Typical life span is 20 years from filing; maintenance fees in relevant jurisdictions impact enforceability.

Competitor and Prior Art Analysis

  • Prior Art Citations: Review of citing patents and literature helps identify the technological space. Analyzing cited references reveals potential overlaps and narrowness.
  • Inter publications and Literature: Searching scientific literature for similar compounds or methods aids in contextualizing novelty and inventive step.

Patentability and Challenges

  • Novelty and Inventive Step: If the claims cover a compound or process previously undisclosed, enforceability is stronger.
  • Potential Challenges: Existing prior art in pharmaceutical chemistry or therapeutic methods could threaten validity, especially if the claims are broad.

Geographical Patent Strategy

Given NZ’s status as a relatively small market, the strategic utility of NZ591443 hinges on:

  • Regional Protection: Aligning patent rights with key markets via PCT filings or direct filings.
  • Market licensing: Licensing or collaborations shaped by the jurisdiction-specific patent rights.

Implications for Stakeholders

  • Pharmaceutical Companies: The scope determines freedom-to-operate and potential licensing opportunities.
  • Innovators: Designs with narrow claims may require supplementary patents or combinations to secure market exclusivity.
  • Legal Practitioners: Need to scrutinize claim language and prior art for potential infringements or validity issues.

Conclusion

NZ591443's claims likely encompass specific chemical, method, or use claims contingent on the language and strategy employed during prosecution. Its positioning within the patent landscape depends on claim breadth, jurisdictional family, and Prior Art. A strategic review of similar patents, literature, and potential challenges is essential for stakeholders to leverage or navigate this patent effectively.


Key Takeaways

  • Assess the exact language of NZ591443’s claims to determine enforceable scope.
  • Broader claims increase exclusivity but are more vulnerable; narrow claims offer lower risk but limited commercial scope.
  • The patent family and related filings impact overall patent protection and patentability in global markets.
  • Continual monitoring of prior art and potential challenges is essential for maintaining patent strength.
  • Strategic prosecution and licensing should align with the patent’s territorial rights and claim coverage.

FAQs

1. What is the primary inventive element of NZ591443?
The core inventive aspect depends on specific claims—likely a novel pharmaceutical compound, formulation, or method of manufacture. Exact details require access to the patent document.

2. How broad are the claims of NZ591443?
The breadth is determined by the language used—either narrow, specific chemical or process claims, or broader use or class-based claims. A detailed claim analysis would clarify this.

3. How does NZ591443 compare to similar patents worldwide?
Comparison involves identifying patent family members, prior art citations, and claims scope. A patent landscape report would be necessary for comprehensive insights.

4. What strategic considerations should stakeholders have regarding NZ591443?
Stakeholders should evaluate territorial coverage, claim strength, expiration dates, and potential infringement risks to align licensing, enforcement, or design-around strategies.

5. Can NZ591443 be challenged successfully?
Potential challenges hinge on prior art, claim clarity, and inventive step. Thorough validity assessments are necessary before enforcement actions.


References

  1. [1] Official patent document of NZ591443, available through the Intellectual Property Office of New Zealand (IPONZ).
  2. [2] World Intellectual Property Organization (WIPO) PatentScope database for family family searches.
  3. [3] PATENTSCOPE and Espacenet for prior art and landscape analysis.
  4. [4] Patent law principles and analysis guides relevant to NZ patent law and international standards.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.